Solugen has raised $675.5M across 6 funding rounds, plus 1 undated round. The latest round valued Solugen at $2B post-money, with Idealist Capital, Canada Growth Fund on the lead line.
Solugen has raised more than $640 million, including a $13.5 million Series A round led by Fifty Years, Founders Fund and Y Combinator, a $32 million Series B, and over $350 million in Series C funding led by GIC and Baillie Gifford. In 2024 it also secured a conditional $213.6 million loan guarantee from the U.S. Department of Energy to scale domestic biomanufacturing.
6 funding rounds, the latest highlighted.
Solugen was founded in 2016, United States.
No date is disclosed for this round.
A primary round — the company sells new shares to investors it selects. $13.5M raised.
A primary round — the company sells new shares to investors it selects. $32M raised.
Refactor Capital, Y Combinator. $30M raised.
A primary round — the company sells new shares to investors it selects. $350M raised, led by GIC, Baillie Gifford.
A primary round — the company sells new shares to investors it selects. $200M raised, led by Kinnevik, Lowercarbon Capital, Refactor Capital.
A primary round — the company sells new shares to investors it selects. $50M raised, led by Idealist Capital, Canada Growth Fund.
No filing has been made.
6 dated rounds, newest first.
Y CombinatorLEADIIdealist CapitalLEADCCanada Growth FundLEADKKinnevikLEAD
Lowercarbon CapitalLEADRRefactor CapitalLEADGGICLEAD
Baillie GiffordLEAD
Breakthrough Energy VenturesThe routes section explains what is realistically available for a company at this stage.
No. Solugen is a private company; its shares do not trade on a public exchange.
The last valuation is $2B (post-money, Mar 2026).
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
